IPO Monitor: Latest IPO News (beta)

[ All Markets | U.S. | Canada | Europe | China ]

Insurance costs rocket for U.S. IPOs as twitchy investors take to courts

Companies going public in the United States face insurance costs that have increased as much as 200% in the last three years to cover their executives against lawsuits alleging they misled investors.
[ Fidelity at 2019-06-17 13:43:11 ]

Adaptive Biotechnologies IPO: Five things to know

Adaptive may have broken the code to the human immune system, and hopes to develop screening technology' like an MRI or X-ray'. Adaptive Biotechnologies Corp., a life-sciences research and clinical diagnostics company that says data from the immune system is the key to diagnosing and treating diseases, is planning to go public. The company set terms for its initial public offering on Monday.
[ Fidelity at 2019-06-17 11:10:28 ]

Adaptive Biotechnologies IPO: Five things to know

BridgeBio Pharma to raise up to $240 million, as terms set for IPO

BridgeBio Pharma Inc. disclosed Monday that it set terms for its initial public offering, in which the drug discovery company to treat genetic diseases is expected to raise up to $240 million and be valued at about $1.84 billion. The Palo Alto, Calif.-based company is offering 15 million shares in the IPO, which is expected to price between $14 and $16 a share. If the underwriters, led by J.P.
[ Fidelity at 2019-06-17 10:46:32 ]

More choice for IPO lawsuits in U.S. spur 200% increase in some exec insurance

Adaptive Biotechnologies sets terms for IPO, to raise up to $212.5 million

Adaptive Biotechnologies Corp. set terms for its initial public offering Monday, in which the developer of immune- system derived disease treatments is expected to raise up to $212.5 million and be valued at about $2.01 billion. The Seattle-based company is offering 12.5 million shares in the IPO, which is expected to price between $15 and $17 a share. If the underwriters, led by Goldman Sachs, J.P.
[ Fidelity at 2019-06-17 10:31:39 ]

Karuna Therapeutics sets IPO terms, to be valued at up to $363 million

Karuna Therapeutics Inc. set terms Monday for its initial public offering, in which the biopharmaceutical company developing treatments for neuropsychiatric conditions is expected to raise up to $74.4 million and be valued at about$ 363.3 million. The company is offering 4.375 million shares in the IPO, which is expected to price between $15 and $17 a share. The stock is expected to list on the Nasdaq under the ticker symbol "KRTX."
[ Fidelity at 2019-06-17 10:18:02 ]

BRIEF-Pointsbet Announces Pricing Of Global Initial Public Offering

* POINTSBET ANNOUNCES PRICING OF GLOBAL INITIAL PUBLIC OFFERING. * POINTSBET - SHARES WERE ISSUED AT OFFER PRICE OF $2.00 PER SHARE Source text for Eikon: Further company coverage: [ ]
[ Fidelity at 2019-06-17 09:09:13 ]

Priam Properties sets terms for IPO, to raise up to $180 million

Priam Properties Inc. set terms Monday for its initial public offering, in which the Nashville-based real estate investment trust expects to raise up to $180 million and be valued at about $233.51 million. The newly formed REIT, which is focused on acquiring and owning multi-tenant office urban properties in the Midwest and Southeast, with a particular focus on millennials, is offering 9 million shares, with the IPO expected to price between $18 and $20 a share.
[ Fidelity at 2019-06-17 05:04:27 ]

The RealReal sets IPO terms, to be valued at up to $1.6 billion

The RealReal Inc. set terms Monday for its initial public offering, in which the online consigned luxury goods seller expects to raise up to $285 million and be valued at about $1.57 billion. The company is offering 15 million shares, with the IPO expected to price between $17 and $19 a share. The stock is expected to list on the Nasdaq under the ticker symbol "REAL."
[ Fidelity at 2019-06-17 04:45:17 ]

BRIEF-Priam Properties Expects IPO Price Of Common Stock To Be Between $18.00 And $20.00 Per Share

Priam Properties Inc: * PRIAM PROPERTIES INC SAYS EXPECTS INITIAL PUBLIC OFFERING PRICE OF COMMON STOCK TO BE BETWEEN $18.00 AND $20.00 PER SHARE - SEC FILING. * PRIAM PROPERTIES INC SEES IPO OF UP TO 9.0 MILLION SHARES OF COMMON STOCK Source text: Further company coverage:
[ Fidelity at 2019-06-17 04:09:16 ]

BRIEF-BridgeBio Pharma Sees IPO Of 15 Mln Shares Priced To Be Between $14 And $16 Per Share

BridgeBio Pharma Inc: * BRIDGEBIO PHARMA SEES IPO OF 15 MILLION SHARES PRICED TO BE BETWEEN $14 AND $16 PER SHARE Â SEC FILING Source text: Further company coverage:
[ Fidelity at 2019-06-17 03:57:40 ]

BRIEF-Karuna Therapeutics Says Estimated IPO Price Will Be Between $15.00 And $17.00 Per Share

Karuna Therapeutics Inc: * KARUNA THERAPEUTICS INC SAYS ESTIMATED INITIAL PUBLIC OFFERING PRICE WILL BE BETWEEN $15.00 AND $17.00 PER SHARE - SEC FILING. * KARUNA THERAPEUTICS INC SEES IPO OF UP TO 4.4 MILLION SHARES OF COMMON STOCK.
[ Fidelity at 2019-06-17 03:56:47 ]

BRIEF-Adaptive Biotechnologies Says Estimated Initial Public Offering Price Will Be Between $15 And $17 Per Share

Adaptive Biotechnologies Corp: * ADAPTIVE BIOTECHNOLOGIES CORP SAYS ESTIMATED INITIAL PUBLIC OFFERING PRICE WILL BE BETWEEN $15.00 AND $17.00 PER SHARE - SEC FILING. * ADAPTIVE BIOTECHNOLOGIES CORP SEES IPO OF UP TO 12.5 MILLION SHARES OF COMMON STOCK.
[ Fidelity at 2019-06-17 03:52:35 ]

BRIEF-RealReal Inc Sees IPO Of 15 Million Shares Priced To Be Between $17 And $19 Per Share

RealReal Inc: * REALREAL INC SEES IPO OF 15 MILLION SHARES PRICED TO BE BETWEEN $17 AND $19 PER SHARE Â SEC FILING. * REALREAL INC - GRANTED UNDERWRITERS 30-DAY OPTION TO PURCHASE UP TO 2.3 MILLION ADDITIONAL SHARES OF COMMON STOCK Source text: Further company coverage:
[ Fidelity at 2019-06-17 03:38:04 ]

JD.com may list logistics unit in future but no plan currently-exec

Chinese e-commerce giant JD.com Inc (JD) may list its logistics unit in the future but it currently has no clear plan, a senior company executive said on Monday. Bing Fu, head of planning and development at JD Logistics, made the comments to reporters on the sidelines of a media tour.
[ Fidelity at 2019-06-17 02:02:37 ]

CrowdStrike stock nearly doubles after IPO, CEO compares security company to Salesforce and ServiceNow

By Jeremy C. Owens, MarketWatch, Emily Bary. IPO raises at least $610 million at valuation nearing $7 billion. CrowdStrike Holdings Inc. (CRWD) shares soared nearly 100% at times in their trading debut Wednesday, and the chief executive compared the cybersecurity company to cloud-software giants like Salesforce.com Inc. and ServiceNow Inc. while watching the stock's huge first-day pop.
[ Fidelity at 2019-06-15 09:12:51 ]

Chewy IPO: 5 things to know about the 'pet humanization' products seller

Shares blast off as first trade at $36 was 64% above IPO price. Shares of Chewy Inc. (CHWY) rocketed in their public debut Friday, as investors looked to buy into the rapidly growing online seller that says it is feeding on a "pet humanization" trend. Chewy announced late Thursday that it planned to sell at least 46.5 million shares at $22 apiece, which would bring in more than $1 billion at an initial valuation approaching $9 billion.
[ Fidelity at 2019-06-14 12:27:26 ]

Chewy IPO: 5 things to know about the 'pet humanization' products seller

Shares blast off as first trade at $36 is 64% above IPO price. Shares of Chewy Inc. (CHWY) rocketed in their public debut Friday, as investors looked to buy into the rapidly growing online seller that says it is feeding on a "pet humanization" trend. Chewy announced late Thursday that it planned to sell at least 46.5 million shares at $22 apiece, which would bring in more than $1 billion at an initial valuation approaching $9 billion.
[ Fidelity at 2019-06-14 08:21:31 ]

Chewy's stock soars at the open, boosting market cap to nearly $15 billion

Shares of Chewy Inc. (CHWY) took flight at their open Friday, to trade 72% above the $22 initial public offering price. The stock's first trade was at $36 at 11:03 a.m. Eastern for 6.1 million shares, then kept rising. The pet e-tailer's IPO priced late Thursday above the expected range of $19 to $21 a share, which was recently raised from $17 to $19. The company raised $129.8 million in the IPO through the sale of 5.6 million shares, while its biggest shareholder, parent PetSmart Inc., raised...
[ Fidelity at 2019-06-14 08:07:27 ]

More IPO News >>



Initial Public Offerings IPO News (beta) Recent Filings IPO Calendar Recent Pricings IPO Withdrawals Quiet Period Deal Flow Lockup Expirations Best-Worst Performers Industry Analysis Underwriter Performance Quarterly Reviews Secondary Offerings Recent Filings Calendar Recent Pricings Quiet Period Deal Flow Best-Worst Performers Industry Analysis Underwriter Performance Quarterly Reviews Tools Search Recent Events Underwriters Aftermarket Report	Latest IPO News (beta) [ All Markets \| U.S. \| Canada \| Europe \| China ] Insurance costs rocket for U.S. IPOs as twitchy investors take to courts Companies going public in the United States face insurance costs that have increased as much as 200% in the last three years to cover their executives against lawsuits alleging they misled investors. [ Fidelity at 2019-06-17 13:43:11 ] Adaptive Biotechnologies IPO: Five things to know Adaptive may have broken the code to the human immune system, and hopes to develop screening technology' like an MRI or X-ray'. Adaptive Biotechnologies Corp., a life-sciences research and clinical diagnostics company that says data from the immune system is the key to diagnosing and treating diseases, is planning to go public. The company set terms for its initial public offering on Monday. [ Fidelity at 2019-06-17 11:10:28 ] Adaptive Biotechnologies IPO: Five things to know Adaptive may have broken the code to the human immune system, and hopes to develop screening technology' like an MRI or X-ray'. Adaptive Biotechnologies Corp., a life-sciences research and clinical diagnostics company that says data from the immune system is the key to diagnosing and treating diseases, is planning to go public. The company set terms for its initial public offering on Monday. [ Fidelity at 2019-06-17 10:52:43 ] BridgeBio Pharma to raise up to $240 million, as terms set for IPO BridgeBio Pharma Inc. disclosed Monday that it set terms for its initial public offering, in which the drug discovery company to treat genetic diseases is expected to raise up to $240 million and be valued at about $1.84 billion. The Palo Alto, Calif.-based company is offering 15 million shares in the IPO, which is expected to price between $14 and $16 a share. If the underwriters, led by J.P. [ Fidelity at 2019-06-17 10:46:32 ] More choice for IPO lawsuits in U.S. spur 200% increase in some exec insurance Companies going public in the United States face insurance costs that have increased as much as 200% in the last three years to cover their executives against lawsuits alleging they misled investors. [ Fidelity at 2019-06-17 10:35:04 ] Adaptive Biotechnologies sets terms for IPO, to raise up to $212.5 million Adaptive Biotechnologies Corp. set terms for its initial public offering Monday, in which the developer of immune- system derived disease treatments is expected to raise up to $212.5 million and be valued at about $2.01 billion. The Seattle-based company is offering 12.5 million shares in the IPO, which is expected to price between $15 and $17 a share. If the underwriters, led by Goldman Sachs, J.P. [ Fidelity at 2019-06-17 10:31:39 ] Karuna Therapeutics sets IPO terms, to be valued at up to $363 million Karuna Therapeutics Inc. set terms Monday for its initial public offering, in which the biopharmaceutical company developing treatments for neuropsychiatric conditions is expected to raise up to $74.4 million and be valued at about$ 363.3 million. The company is offering 4.375 million shares in the IPO, which is expected to price between $15 and $17 a share. The stock is expected to list on the Nasdaq under the ticker symbol "KRTX." [ Fidelity at 2019-06-17 10:18:02 ] BRIEF-Pointsbet Announces Pricing Of Global Initial Public Offering * POINTSBET ANNOUNCES PRICING OF GLOBAL INITIAL PUBLIC OFFERING. * POINTSBET - SHARES WERE ISSUED AT OFFER PRICE OF $2.00 PER SHARE Source text for Eikon: Further company coverage: [ ] [ Fidelity at 2019-06-17 09:09:13 ] Priam Properties sets terms for IPO, to raise up to $180 million Priam Properties Inc. set terms Monday for its initial public offering, in which the Nashville-based real estate investment trust expects to raise up to $180 million and be valued at about $233.51 million. The newly formed REIT, which is focused on acquiring and owning multi-tenant office urban properties in the Midwest and Southeast, with a particular focus on millennials, is offering 9 million shares, with the IPO expected to price between $18 and $20 a share. [ Fidelity at 2019-06-17 05:04:27 ] The RealReal sets IPO terms, to be valued at up to $1.6 billion The RealReal Inc. set terms Monday for its initial public offering, in which the online consigned luxury goods seller expects to raise up to $285 million and be valued at about $1.57 billion. The company is offering 15 million shares, with the IPO expected to price between $17 and $19 a share. The stock is expected to list on the Nasdaq under the ticker symbol "REAL." [ Fidelity at 2019-06-17 04:45:17 ] BRIEF-Priam Properties Expects IPO Price Of Common Stock To Be Between $18.00 And $20.00 Per Share Priam Properties Inc: * PRIAM PROPERTIES INC SAYS EXPECTS INITIAL PUBLIC OFFERING PRICE OF COMMON STOCK TO BE BETWEEN $18.00 AND $20.00 PER SHARE - SEC FILING. * PRIAM PROPERTIES INC SEES IPO OF UP TO 9.0 MILLION SHARES OF COMMON STOCK Source text: Further company coverage: [ Fidelity at 2019-06-17 04:09:16 ] BRIEF-BridgeBio Pharma Sees IPO Of 15 Mln Shares Priced To Be Between $14 And $16 Per Share BridgeBio Pharma Inc: * BRIDGEBIO PHARMA SEES IPO OF 15 MILLION SHARES PRICED TO BE BETWEEN $14 AND $16 PER SHARE Â SEC FILING Source text: Further company coverage: [ Fidelity at 2019-06-17 03:57:40 ] BRIEF-Karuna Therapeutics Says Estimated IPO Price Will Be Between $15.00 And $17.00 Per Share Karuna Therapeutics Inc: * KARUNA THERAPEUTICS INC SAYS ESTIMATED INITIAL PUBLIC OFFERING PRICE WILL BE BETWEEN $15.00 AND $17.00 PER SHARE - SEC FILING. * KARUNA THERAPEUTICS INC SEES IPO OF UP TO 4.4 MILLION SHARES OF COMMON STOCK. [ Fidelity at 2019-06-17 03:56:47 ] BRIEF-Adaptive Biotechnologies Says Estimated Initial Public Offering Price Will Be Between $15 And $17 Per Share Adaptive Biotechnologies Corp: * ADAPTIVE BIOTECHNOLOGIES CORP SAYS ESTIMATED INITIAL PUBLIC OFFERING PRICE WILL BE BETWEEN $15.00 AND $17.00 PER SHARE - SEC FILING. * ADAPTIVE BIOTECHNOLOGIES CORP SEES IPO OF UP TO 12.5 MILLION SHARES OF COMMON STOCK. [ Fidelity at 2019-06-17 03:52:35 ] BRIEF-RealReal Inc Sees IPO Of 15 Million Shares Priced To Be Between $17 And $19 Per Share RealReal Inc: * REALREAL INC SEES IPO OF 15 MILLION SHARES PRICED TO BE BETWEEN $17 AND $19 PER SHARE Â SEC FILING. * REALREAL INC - GRANTED UNDERWRITERS 30-DAY OPTION TO PURCHASE UP TO 2.3 MILLION ADDITIONAL SHARES OF COMMON STOCK Source text: Further company coverage: [ Fidelity at 2019-06-17 03:38:04 ] JD.com may list logistics unit in future but no plan currently-exec Chinese e-commerce giant JD.com Inc (JD) may list its logistics unit in the future but it currently has no clear plan, a senior company executive said on Monday. Bing Fu, head of planning and development at JD Logistics, made the comments to reporters on the sidelines of a media tour. [ Fidelity at 2019-06-17 02:02:37 ] CrowdStrike stock nearly doubles after IPO, CEO compares security company to Salesforce and ServiceNow By Jeremy C. Owens, MarketWatch, Emily Bary. IPO raises at least $610 million at valuation nearing $7 billion. CrowdStrike Holdings Inc. (CRWD) shares soared nearly 100% at times in their trading debut Wednesday, and the chief executive compared the cybersecurity company to cloud-software giants like Salesforce.com Inc. and ServiceNow Inc. while watching the stock's huge first-day pop. [ Fidelity at 2019-06-15 09:12:51 ] Chewy IPO: 5 things to know about the 'pet humanization' products seller Shares blast off as first trade at $36 was 64% above IPO price. Shares of Chewy Inc. (CHWY) rocketed in their public debut Friday, as investors looked to buy into the rapidly growing online seller that says it is feeding on a "pet humanization" trend. Chewy announced late Thursday that it planned to sell at least 46.5 million shares at $22 apiece, which would bring in more than $1 billion at an initial valuation approaching $9 billion. [ Fidelity at 2019-06-14 12:27:26 ] Chewy IPO: 5 things to know about the 'pet humanization' products seller Shares blast off as first trade at $36 is 64% above IPO price. Shares of Chewy Inc. (CHWY) rocketed in their public debut Friday, as investors looked to buy into the rapidly growing online seller that says it is feeding on a "pet humanization" trend. Chewy announced late Thursday that it planned to sell at least 46.5 million shares at $22 apiece, which would bring in more than $1 billion at an initial valuation approaching $9 billion. [ Fidelity at 2019-06-14 08:21:31 ] Chewy's stock soars at the open, boosting market cap to nearly $15 billion Shares of Chewy Inc. (CHWY) took flight at their open Friday, to trade 72% above the $22 initial public offering price. The stock's first trade was at $36 at 11:03 a.m. Eastern for 6.1 million shares, then kept rising. The pet e-tailer's IPO priced late Thursday above the expected range of $19 to $21 a share, which was recently raised from $17 to $19. The company raised $129.8 million in the IPO through the sale of 5.6 million shares, while its biggest shareholder, parent PetSmart Inc., raised... [ Fidelity at 2019-06-14 08:07:27 ] More IPO News >>